Barbey F - Search Results

1

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.

Schmied C, Nowak A, Gruner C, Olinger E, Debaix H, Brauchlin A, Frank M, Reidt S, Monney P, Barbey F, Shah D, Namdar M. Schmied C, et al. Among authors: barbey f. Heart. 2016 Aug 15;102(16):1309-14. doi: 10.1136/heartjnl-2015-308897. Epub 2016 Apr 7. Heart. 2016. PMID: 27056970

2

Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy.

Monney P, Qanadli SD, Hajdu S, Tran C, Schwitter J, Dormond O, Barbey F. Monney P, et al. Among authors: barbey f. Swiss Med Wkly. 2017 Nov 9;147:w14517. doi: 10.4414/smw.2017.14517. eCollection 2017. Swiss Med Wkly. 2017. PMID: 29120015 Free article.

3

[Isolated left ventricular hypertrophy : is it a Fabry disease?].

Barbey F, Dormond O, Monzambani V, Barbey G, Namdar M, Monney P. Barbey F, et al. Among authors: barbey g. Rev Med Suisse. 2020 Oct 7;16(709):1886-1890. Rev Med Suisse. 2020. PMID: 33026733 Review. French.

4

[Chaperone molecules: The example of Fabry disease].

Barbey F, Monney P, Dormond O. Barbey F, et al. Nephrol Ther. 2021 Apr;17S:S11-S22. doi: 10.1016/j.nephro.2020.02.005. Nephrol Ther. 2021. PMID: 33910691 Free article. French.

5

Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study.

Franzen DP, Nowak A, Haile SR, Mottet D, Bonani M, Dormond O, Kohler M, Krayenbuehl PA, Barbey F. Franzen DP, et al. Among authors: barbey f. PLoS One. 2017 Jul 25;12(7):e0180437. doi: 10.1371/journal.pone.0180437. eCollection 2017. PLoS One. 2017. PMID: 28742806 Free PMC article. Clinical Trial.

6

Long-term Outcomes of Kidney Transplantation in Fabry Disease.

Ersözlü S, Desnick RJ, Huynh-Do U, Canaan-Kühl S, Barbey F, Genitsch V, Mueller TF, Cheetham M, Flammer AJ, Schaub S, Nowak A. Ersözlü S, et al. Among authors: barbey f. Transplantation. 2018 Nov;102(11):1924-1933. doi: 10.1097/TP.0000000000002252. Transplantation. 2018. PMID: 29688992 Free article.

7

Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort.

Nowak A, Huynh-Do U, Krayenbuehl PA, Beuschlein F, Schiffmann R, Barbey F. Nowak A, et al. Among authors: barbey f. J Inherit Metab Dis. 2020 Mar;43(2):326-333. doi: 10.1002/jimd.12167. Epub 2019 Sep 30. J Inherit Metab Dis. 2020. PMID: 31449323 Free article.

8

Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.

Nowak A, Dormond O, Monzambani V, Huynh-Do U, Barbey F. Nowak A, et al. Among authors: barbey f. Mol Genet Metab. 2022 Sep-Oct;137(1-2):173-178. doi: 10.1016/j.ymgme.2022.08.003. Epub 2022 Aug 23. Mol Genet Metab. 2022. PMID: 36087505 Free article.

9

Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.

Oliveira JP, Nowak A, Barbey F, Torres M, Nunes JP, Teixeira-E-Costa F, Carvalho F, Sampaio S, Tavares I, Pereira O, Soares AL, Carmona C, Cardoso MT, Jurca-Simina IE, Spada M, Ferreira S, Germain DP. Oliveira JP, et al. Among authors: barbey f. Eur J Med Genet. 2020 Feb;63(2):103703. doi: 10.1016/j.ejmg.2019.103703. Epub 2019 Jun 11. Eur J Med Genet. 2020. PMID: 31200018

10

Fabry in the older patient: Clinical consequences and possibilities for treatment.

Lidove O, Barbey F, Niu DM, Brand E, Nicholls K, Bizjajeva S, Hughes DA. Lidove O, et al. Among authors: barbey f. Mol Genet Metab. 2016 Aug;118(4):319-25. doi: 10.1016/j.ymgme.2016.05.009. Epub 2016 May 14. Mol Genet Metab. 2016. PMID: 27221354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters